Adzenys XR-ODT 12.5 MG tablet UD 30S
Ended Awarded
- Contract number
- SPE2DB25FD9RQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,866
Award facts
- Contract value 100% obligated
- $1,865.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,865.67 to AmerisourceBergen Drug Corp for the supply of Adzenys XR-ODT 12.5 mg tablets (30-count unit dose packages) with a completion date of September 30, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems through competitively awarded contracts with the DLA Medical Supply Chain. Adzenys XR-ODT is an amphetamine-based medication used to treat attention-deficit/hyperactivity disorder (ADHD), demonstrating the company's role in supplying specialized neurological and psychiatric medications alongside its broader pharmaceutical portfolio. The DLA Troop Support Medical contract vehicle provides a flexible procurement mechanism for delivering diverse pharmaceutical products, including brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FD9RQ?
SPE2DB25FD9RQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FD9RQ worth?
The government has obligated $1,866 on SPE2DB25FD9RQ.
Is contract SPE2DB25FD9RQ an order under another contract?
Yes. SPE2DB25FD9RQ is a delivery order under SPE2DB20D1051, an indefinite delivery contract.
Was contract SPE2DB25FD9RQ competed?
The extent of competition for SPE2DB25FD9RQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award